Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

European Research Council grant · Running

LAB-Protect Lab-Protect: Translating phyllosphere-adapted microbial insights into a new class of lactobacilli-based biocontrol solutions

Coordinator
Universiteit Antwerpen, Belgium
Runs
1 December 2026 to 31 May 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101334834

What the project is doing

In the project's own words, from its summary on CORDIS.

Transitioning to sustainable crop protection is a pillar of the European Green Deal, calling for a 50% reduction in chemical pesticide use by 2030. This requires reliable, field-robust biological alternatives. LAB-Protect builds on the ERC StG Lacto Be and aims to develop next-generation microbial biocontrol agents (MBCAs) based on plant-derived lactic acid bacteria (LAB), an underexploited yet highly promising class of beneficial microbes.

One lead strain isolated from strawberry tissue shows exceptionally potent inhibition of fungal and bacterial plant pathogens and retains its antagonistic activity after spray-drying, enabling stable formulation and long-term storage. Importantly, this strain demonstrated robust disease suppression directly on plants, overcoming the major bottleneck where most MBCAs fail to translate from in vitro assays to real plant systems.

Additional plant-associated LAB strains show complementary biocontrol and formulation traits, further expanding the technology’s potential. LAB-Protect focuses on de-risking and strengthening the innovation potential of this technology. Specifically, we will (i) substantiate the strain’s previously observed in silico safety profile through, among others, targeted cell-line experiments and consulting with the European responsible authorities to support fast-track regulation, (ii) elucidate the mode of action underlying its potent antipathogenic activity and identify the chemical structure of the bioactive metabolite responsible, and (iii) scale up and validate in planta efficacy in additional crop-pathogen systems to demonstrate multi-crop applicability.

These activities will elevate the technology beyond its current proof-of-concept stage, reinforce IP positioning, and attract industrial capital. Our ultimate goal is to deliver a differentiated, patent-protected biocontrol product and secure commercial deployment through a spin-off or licensing partnership.

Topics

Who is involved

OrganisationCityCountryRole
Universiteit AntwerpenAntwerpenBelgiumCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI